These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10048913)

  • 1. CCR5, vertical transmission of HIV-1, and disease progression. European Collaborative Study.
    Bailey AJ; Newell ML; De Rossi A; Giaquinto C; Iasci A; Ravizza M; Garcia-Rodriguez MC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):211-2. PubMed ID: 10048913
    [No Abstract]   [Full Text] [Related]  

  • 2. CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.
    Villalba N; Pérez-Olmeda M; de José M; Hernández M; Sirera R; Español T; González-Molina A; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 May; 18(5):389-91. PubMed ID: 10421054
    [No Abstract]   [Full Text] [Related]  

  • 3. CCR5 genotype and mother-to-child HIV transmission.
    Rascoff H
    JAMA; 1998 Jun; 279(24):1953. PubMed ID: 9643856
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission.
    Mangano A; Prada F; Roldán A; Picchio G; Bologna R; Sen L
    AIDS; 1998 Jan; 12(1):109-10. PubMed ID: 9456261
    [No Abstract]   [Full Text] [Related]  

  • 5. CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study Group.
    Shearer WT; Kalish LA; Zimmerman PA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):180-1. PubMed ID: 9473022
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.
    Edelstein RE; Arcuino LA; Hughes JP; Melvin AJ; Mohan KM; King PD; McLellan CL; Murante BL; Kassman BP; Frenkel LM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):243-6. PubMed ID: 9402070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 genotype and HIV-1 infection in perinatally-exposed infants.
    Mas A; Español T; Heredia A; Pedraza MA; Hernandez M; Caragol I; Fernando M; Bertran JM; Alcami J; Soriano V
    J Infect; 1999 Jan; 38(1):9-11. PubMed ID: 10090498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression.
    Esposito S; Zehender G; Zuccotti GV; Vegni C; Galli L; Vecchi V; Agostoni C; Rancilio L; De Maddalena C; Clerici M; Principi N
    Pediatr Infect Dis J; 1998 Sep; 17(9):847-9. PubMed ID: 9779780
    [No Abstract]   [Full Text] [Related]  

  • 9. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
    Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
    JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HIV isolates from Puerto Rican maternal-infant pairs reveal predominance of non-syncytium inducing (NSI) variants with CCR5 genotype.
    Melendez-Guerrero LM; Arroyo MA; Vega ME; Jimenez E; Hillyer GV; Cadilla CL
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL39-47. PubMed ID: 11936872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of natural chemokine receptor polymorphisms on perinatal transmission of human immunodeficiency virus type 1.
    Kostrikis LG
    Teratology; 2000 May; 61(5):387-90. PubMed ID: 10777836
    [No Abstract]   [Full Text] [Related]  

  • 12. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
    Mangano A; Gonzalez E; Dhanda R; Catano G; Bamshad M; Bock A; Duggirala R; Williams K; Mummidi S; Clark RA; Ahuja SS; Dolan MJ; Bologna R; Sen L; Ahuja SK
    J Infect Dis; 2001 Jun; 183(11):1574-85. PubMed ID: 11335892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 haplotypes and mother-to-child HIV transmission in Malawi.
    Pedersen BR; Kamwendo D; Blood M; Mwapasa V; Molyneux M; North K; Rogerson SJ; Zimmerman P; Meshnick SR
    PLoS One; 2007 Sep; 2(9):e838. PubMed ID: 17786209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mother-to-infant transmission of HIV-1: the placenta fights back.
    Spector SA
    J Clin Invest; 2001 Feb; 107(3):267-9. PubMed ID: 11160148
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.
    Ometto L; Zanchetta M; Mainardi M; De Salvo GL; Garcia-Rodriguez MC; Gray L; Newell ML; Chieco-Bianchi L; De Rossi A
    AIDS; 2000 Aug; 14(12):1721-9. PubMed ID: 10985308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.
    Joubert BR; Franceschini N; Mwapasa V; North KE; Meshnick SR
    PLoS One; 2010 Feb; 5(2):e9212. PubMed ID: 20169157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.